Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Your RPS

RPS members to advise government on the misuse of drugs

Carole Hunter, David Taylor and Roger Knaggs are among six new appointees to the Advisory Council on the Misuse of Drugs.

Carole Hunter

Source: Julia Robinson / The Pharmaceutical Journal

Carole Hunter, who joins the Advisory Council on the Misuse of Drugs alongside Roger Knaggs, is seen here lecturing on novel psychoactive substances at the 2016 RPS annual conference

Three members of the Royal Pharmaceutical Society have been appointed to the Advisory Council on the Misuse of Drugs (ACMD), an expert body that advises the government on drugs that have potential to be misused.

The appointment of Carole Hunter, Roger Knaggs and David Taylor was announced on 16 January 2018. Hunter, Knaggs and Taylor will hold their appointments, which were approved by the home secretary Sajid Javid, for three years.

Hunter is lead pharmacist at the Alcohol and Drug Recovery Services at NHS Greater Glasgow and Clyde health board. She has previously chaired the Scottish Specialist Pharmacists in Substance Misuse group and currently chairs the National Naloxone Advisory group.

Taylor is the director of pharmacy and pathology at the Maudsley Hospital and professor of psychopharmacology at Kings College London.

Knaggs is an associate professor in clinical pharmacy practice at the University of Nottingham and has prior experience as a hospital pharmacist.

Speaking of his appointment to the ACMD, Knaggs said that “with the current interest in the medical use of cannabis for various illnesses and misuse of prescription medicines, it is going to be a very interesting period to ensure legitimate clinical use while maintaining adequate controls to minimise misuse”.

The council advised the Home Office in July 2018 that medical cannabis should be rescheduled, concluding that “there is now evidence of medicinal benefit for some cannabis-derived products in certain medical conditions for some patients”.


  • This article was corrected on 22 January 2019 to include the appointment of David Taylor, who is also a member of the Royal Pharmaceutical Society

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2019.20206024

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • Pharmaceutical Statistics

    Pharmaceutical Statistics

    This book on basic statistics has been specifically written for pharmacy students.

    £33.00Buy now
  • Drugs of Abuse

    Drugs of Abuse

    A concise, easy-to-read guide for healthcare professionals who encounter drug abuse.

    £38.00Buy now
  • Pharmaceutical Toxicology

    Pharmaceutical Toxicology

    Explains the methodology and requirements of pre-clinical safety assessments of new medicines. Includes registration requirements and pharmacovigilance.

    £40.00Buy now
  • Paediatric Drug Handling

    Paediatric Drug Handling

    Written for new pharmaceutical scientists, this book provides a background in paediatric pharmacy and a comprehensive introduction to children's medication.

    £33.00Buy now
  • Drugs and the Liver

    Drugs and the Liver

    Drugs and the Liver assists practitioners in making pragmatic choices for their patients. It enables you to assess liver function and covers the principles of drug use in liver disease.

    £38.00Buy now

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
PJJ Static MPU
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Jobs you might like

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.